Englander Institute for Precision Medicine

Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma.

TitleGlobal evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma.
Publication TypeJournal Article
Year of Publication2022
AuthorsAltorki NK, Borczuk AC, Harrison S, Groner LK, Bhinder B, Mittal V, Elemento O, McGraw TE
JournalCell Rep
Volume39
Issue1
Pagination110639
Date Published2022 Apr 05
ISSN2211-1247
KeywordsAdenocarcinoma, Adenocarcinoma of Lung, Humans, Lung Neoplasms, Neoplasm Invasiveness, Retrospective Studies, Tumor Microenvironment
Abstract

To investigate changes in the tumor microenvironment (TME) during lung cancer progression, we interrogate tumors from two chest computed tomography (CT)-defined groups. Pure non-solid (pNS) CT density nodules contain preinvasive/minimally invasive cancers, and solid density nodules contain invasive cancers. Profiling data reveal a dynamic interaction between the tumor and its TME throughout progression. Alterations in genes regulating the extracellular matrix and genes regulating fibroblasts are central at the preinvasive state. T cell-mediated immune suppression is initiated in preinvasive nodules and sustained with rising intensity through progression to invasive tumors. Reduced T cell infiltration of the cancer cell nests is more frequently associated with preinvasive cancers, possibly until tumor evolution leads to a durable, viable invasive phenotype accompanied by more varied and robust immune suppression. Upregulation of immune checkpoints occurs only in the invasive nodules. Throughout progression, an effector immune response is present but is effectively thwarted by the immune-suppressive elements.

DOI10.1016/j.celrep.2022.110639
Alternate JournalCell Rep
PubMed ID35385730
PubMed Central IDPMC9033258
Grant ListR01 CA194547 / CA / NCI NIH HHS / United States
UG3 CA244697 / CA / NCI NIH HHS / United States
UH3 CA244697 / CA / NCI NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021